ReNeuron Group plc
RENE.L · LSE
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£6,657 | -£11,058 | -£13,410 | -£13,858 |
| Dep. & Amort. | £267 | £324 | £380 | £412 |
| Deferred Tax | £0 | £1,788 | £6,025 | -£653 |
| Stock-Based Comp. | £576 | £649 | £764 | £1,203 |
| Change in WC | -£2,648 | £1,056 | -£307 | -£857 |
| Other Non-Cash | £978 | -£170 | £496 | -£551 |
| Operating Cash Flow | -£7,484 | -£7,411 | -£6,052 | -£14,304 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£220 | -£302 | -£25 | -£119 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £4,000 | £2,500 | £0 | £0 |
| Other Inv. Act. | £131 | -£2,474 | £27 | £300 |
| Investing Cash Flow | £3,911 | -£276 | £2 | £181 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £6,260 |
| Stock Issued | £1 | £23 | £17,502 | £188 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£148 | -£157 | -£8,891 | -£299 |
| Financing Cash Flow | -£147 | £2,366 | £8,611 | £6,316 |
| Forex Effect | £325 | £166 | -£483 | £167 |
| Net Chg. in Cash | -£3,395 | -£5,155 | £2,078 | -£7,807 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £9,548 | £14,703 | £12,625 | £20,432 |
| End Cash | £6,153 | £9,548 | £14,703 | £12,625 |
| Free Cash Flow | -£7,704 | -£7,713 | -£6,077 | -£14,423 |